← All companies
AVANOS MEDICAL, INC.
AVNS - CIK 0001606498
Market cap$1.17 B
Rank#2523
SEC filings701
AVANOS MEDICAL, INC. trades as AVNS and has a market capitalization of $1.17 B, making it the #2523 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $701.20M, up 1.9% from the prior year and net income of -$72.90M. This page tracks AVANOS MEDICAL, INC. through 701 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$701.20MFY 2025
Net income (latest FY)-$72.90MFY 2025
Operating cash flow (latest FY)$74.70MFY 2025
Total assets (latest FY)$1.07BFY 2025
Gross margin50.5%latest FY
Net margin-10.4%latest FY
Financial performance
Over the last 9 fiscal years AVANOS MEDICAL, INC.'s revenue grew from $566.20M to $701.20M, a compound annual growth rate of 2.4%. Net profit margin compressed from 7.0% to -10.4% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $1.17 B
- Share price (derived)market cap / shares outstanding
- $24.98
- EPS (diluted)FY 2025
- $-1.57
- Shares outstandingas of 2026-04-28
- 0.05B
- Total equityas of 2026-03-31
- $782.10M
- Return on equity
- -9.3%
- Long-term debtas of 2026-03-31
- $87.30M
- Cash & equivalentsas of 2026-03-31
- $65.60M
Latest filings
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-05-07 |
Recent press releases
- Avanos Medical, Inc. Announces First Quarter 2026 Results - May 5 ...
Delivered double-digit organic growth led by Specialty Nutrition Systems segment; Generated $0.11 of diluted earnings per share and $0.22 of adjusted ...
- Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 ...
In the fourth quarter of 2024, net sales totaled $179.6 million, a 3.6% increase compared to the prior year, primarily due to continued strong performance.
- Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 ...
We expect 2026 net sales to be between $700 million and $720 million, and adjusted diluted earnings per share are expected to be between $0.90 ...
Similar companies
The largest companies sharing AVANOS MEDICAL, INC.'s SEC industry classification (orthopedic, prosthetic & surgical appliances & supplies).
Frequently asked questions
What is AVANOS MEDICAL, INC.'s market cap?
AVANOS MEDICAL, INC. (AVNS) has a market capitalization of $1.17 B as of 2026-06-10, ranking #2523 among US-listed companies.
How much revenue does AVANOS MEDICAL, INC. make?
AVANOS MEDICAL, INC. reported revenue of $701.20M for fiscal year 2025, an increase of 1.9% year over year.
Is AVANOS MEDICAL, INC. profitable?
In its latest fiscal year AVANOS MEDICAL, INC. reported a net loss of $72.90M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.